 Home > Food News > Nutrition News > What you eat matters!

What you eat matters!

 Last Update: 2022-09-08
 Source: Internet
 Author: User

Tags

apples dietary fiber

malignant neoplasm lung

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Original title: What you eat matters! Dietary supplements with lutein and zeaxanthin in place of beta-carotene slow AMD progression, study confirms

Editor's note: The Age-Related Eye Disease Study (AREDS and AREDS2) determined that dietary supplements can slow the progression of age-related macular degeneration (AMD), based on data from the National Eye Institute

AREDS Study Shows: Beta-Carotene-Containing Dietary Supplement Formulations Can Significantly Slow AMD Progress AREDS Study Shows: Beta-Carotene-Containing Dietary Supplement Formulations Can Significantly Slow AMD Progress Dietary supplement formulation can significantly slow AMD progression

The AREDS study, originally initiated in 1996, showed that dietary supplements (500㎎ vitamin C, 400 IU vitamin E, 2㎎ copper, 80㎎ zinc, and 15㎎ beta-carotene) significantly slowed the progression of AMD from intermediate to advanced stages.

Because beta-carotene increased the risk of lung cancer in current smokers in two NIH-backed studies, said lead author Professor Emily Chew, director of the Division of Epidemiology and Clinical Applications at the National Eye Institute

AREDS2 study shows that dietary supplements with lutein and zeaxanthin instead of beta-carotene are better choices AREDS2 study shows: lutein and zeaxanthin are better choices for dietary supplements instead of beta-carotene Dietary supplements with zeaxanthin instead of beta-carotene are better options

In the AREDS2 study, starting in 2006, Prof.

A follow-up study showed that people who initially received dietary supplements containing lutein/zeaxanthin had a lower risk of developing advanced AMD Lower risk of progression to advanced AMD Follow-up study shows lower risk of progression to advanced AMD in people initially receiving lutein/zeaxanthin-containing dietary supplements

In the new report, researchers followed 3,883 of the original 4,203 AREDS2 participants for five years after the AREDS2 study ended in 2011, collecting information on whether participants' AMD progressed to an advanced stage and whether they were diagnosed Lung cancer

Prof Chew concluded that these findings confirm that converting beta-carotene to lutein and zeaxanthin in dietary supplement formulations is the right choice

Reference: https://eyewire.

View more exciting content

(Source: Editorial Department of International Ophthalmology Times)

point share point share

Favorites

point favorite point favorite

Like, like, like, like

click to watch

point to see point to see

Editor:

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.